These data are further supported by a preclinical study in transgenic mice expressing HERV-W Env protein, displaying hyperglycemia and decreased levels of insulin, and by in vitro experiments demonstrating that HERV-W Env protein directly inhibits insulin secretion in human Langerhans islets [105]. Here, ERVW-1 is linked to Hyperglycemia.